Compared with AZD5305, DSB1559 exhibited superior tumor residence time and tumor-to-plasma ratio and significantly reduced tumor growth while enhancing overall survival in a BRCA1-associated immune-competent TNBC model [121]. Here, BRCA1 is linked to neoplasm.